Literature DB >> 17631073

Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.

Allan D Sniderman1, Ingar Holme, Are Aastveit, Curt Furberg, Goran Walldius, Ingmar Jungner.   

Abstract

Age is by far the most powerful risk factor for cardiovascular disease. Moreover, the consequences of age are considered inevitable and irreversible. In this study, we examined whether age is, to a major degree, a modifiable risk factor. In the subjects in the Apolipoprotein-related Mortality Risk (AMORIS) study, we show that fatal myocardial infarction (MI) is uncommon in men before the sixth decade and in women before the seventh. In age-adjusted analyses, the risk of fatal MI increase successively with each decile of the apolipoprotein (apo) B/apoA-I ratio, confirming the importance of the balance of the atherogenic and antiatherogenic lipoproteins as a fundamental determinant of the likelihood of clinical events. We then determined the risk of fatal acute MI over time in the highest decile of the apoB/apoA-I ratio compared with the lowest decile. For the purposes of this analysis, we assume that all events in the lowest decile of the apoB/apoA-I ratio represent the nonmodifiable adverse effects of age. This assumption maximizes the irreversible effects of age. Because the change in age is identical for the subjects in both deciles, the difference in risk between the lowest and highest deciles of the apoB/apoA-I ratio represents the consequence of exposure over time to very high values of this ratio. Exposure is the modifiable element of risk, and it contributed to most of the risk. In conclusion, it appears that not all of the effects of age are irreversible. therefore, outcomes with early prevention might be much more favorable than usually assumed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631073     DOI: 10.1016/j.amjcard.2007.02.086

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.

Authors:  Scott J Denardo; Yan Gong; Wilmer W Nichols; Franz H Messerli; Anthony A Bavry; Rhonda M Cooper-Dehoff; Eileen M Handberg; Annette Champion; Carl J Pepine
Journal:  Am J Med       Date:  2010-08       Impact factor: 4.965

2.  Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.

Authors:  Jennifer G Robinson; Catherine Rahilly-Tierney; Elizabeth Lawler; J Michael Gaziano
Journal:  J Clin Lipidol       Date:  2011-11-07       Impact factor: 4.766

3.  The causal exposure model of vascular disease.

Authors:  Allan D Sniderman; Patrick R Lawler; Ken Williams; George Thanassoulis; Jacqueline de Graaf; Curt D Furberg
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

4.  Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis.

Authors:  George A Kaysen; Lorien S Dalrymple; Barbara Grimes; Glenn M Chertow; John Kornak; Kirsten L Johansen
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

5.  Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.

Authors:  Justo Sierra-Johnson; Rachel M Fisher; Abel Romero-Corral; Virend K Somers; Francisco Lopez-Jimenez; John Ohrvik; Göran Walldius; Mai-Lis Hellenius; Anders Hamsten
Journal:  Eur Heart J       Date:  2008-08-01       Impact factor: 29.983

6.  Relationship of Apolipoproteins with Subclinical Cardiovascular Risk in Youth.

Authors:  Madeline A Czeck; Elise F Northrop; Nicholas G Evanoff; Donald R Dengel; Kyle D Rudser; Aaron S Kelly; Justin R Ryder
Journal:  J Pediatr       Date:  2020-08-11       Impact factor: 4.406

7.  Components of the metabolic syndrome differ between young and old adults in the US population.

Authors:  Andrew D Sumner; Gabriel L Sardi; James F Reed
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

8.  Effect of age on the phenotype of metabolic syndrome in developing country.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi; Mohsen Hosseini; Elham Andalib; Maraym Bakhtiari Boroujeni; Nizal Sarrafzadegan
Journal:  Adv Biomed Res       Date:  2015-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.